MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Comorbidities and medications in Huntington’s disease, Parkinson’s disease and the general population in a US claims database

    L. Ishihara, E. Wild, D. Oliveri (Welwyn Garden City, United Kingdom)

  • Comparative Grey and White Matter Tau Pathology in LBD and PSP using Digital Histologic Measurements

    D. Coughlin, C. Petersen, R. Lobrovich, D. Wolk, A. Siderowf, D. Weintraub, E. Lee, J. Trojanowski, M. Grossman, D. Irwin (Philadelphia, PA, USA)

  • Comparative Study of Dry Needling under Ultrasound Guidance and Extracorporeal Shock Wave Therapy for Myofascial Pain and Spasticity Management

    R. Bubnov, L. Kalika (Kyiv, Ukraine)

  • Comparing motor and neuropathological features of Parkinson’s disease dementia and dementia with Lewy bodies

    D. Hansen, T. Lashley, J. Holton, T. Warner (London, United Kingdom)

  • Comparison between [11C]PE2I PET and [123I]FP-CIT SPECT as markers of DAT expression in early Parkinson’s disease

    T. Yousaf, G. Pagano, H. Wilson, B. Corcoran, G. Vivian, M. Politis (London, United Kingdom)

  • Comparison between the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and the Non-Motor Symptoms Scale (NMSS)

    A. Schrag, A. Rizos, C. Rodriguez-Blazquez, D. Weintraub, KR. Chaudhuri, P. Martinez-Martin (Madrid, Spain)

  • Comparison of autonomic symptoms on Parkinson’s disease and essential tremor with SCOPA-AUT

    J. Gonzalez (Lima, Peru)

  • Comparison of Current DBS Platforms in the United States

    L. Surillo, U. Yazdani, S. Chitnis (Dallas, TX, USA)

  • Comparison of Dementia Patients With and Without Parkinson’s Disease Before Dementia-related Psychosis Occurs: An Administrative Claims Data Analysis

    A. Shim, B. Skoog, V. Abler, N. Rashid, R. Halpern, E. Koep, M. Frazer (San Diego, CA, USA)

  • Comparison of Gene Expression in Parkinson’s Disease and Bipolar Disorder

    FV. Delos Reyes (Quezon City, Philippines)

  • « Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 217
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley